Former Editorial Board

Viktor Adalsteinsson, PhD

Broad Institute of MIT and Harvard, Cambridge, MA, USA

Constance T. Albarracin, MD, PhD

Department of Pathology, MD Anderson Cancer Center, Houston, Texas, USA

Catherine Alix-Panabières, PhD

Laboratory of Rare Human Circulating Cells, University Medical Centre of Montpellier, University of Montpellier, EA2415, Montpellier, France

Lucia Altucci, MD, PhD‬

Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy

Moran Amit, MD, PhD

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Gaetano Aurilio, MD, PhD

European Institute of Oncology, Cancer Center, Milan, Italy

Hamdy A. Azim, MSc, MD

Department of Clinical Oncology, Faculty of Medicine, Cairo University, Cairo, Egypt

Gerald Batist, MDCM, CM, CQ, FRCP (C), FACP, FCAHS

Department of Oncology, McGill University, Montreal, QC, Canada; Segal Cancer Centre, Jewish General Hospital, Montreal, QC, Canada

Ewa Bien, MD, PhD

Department of Pediatrics, Hematology and Oncology, Medical University of Gdańsk, Gdańsk, Poland

Giovanni Blandino, MD

Regina Elena Cancer Institute, Rome, Italy

Alberto Bongiovanni, MD

Osteoncology and Rare Tumors Center, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Paolo Borghetti, MD

Department of Radiation Oncology, Spedali Civili and University of Brescia, Brescia, Italy

Massimo Breccia, MD

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy

Ian Campbell, PhD

Sir Peter MacCallum Department of Oncology and Peter MacCallum Caner Centre, University of Melbourne, Melbourne, VIC, Australia

Federico Cappuzzo, MD

Division of Medical Oncology, National Cancer Institute Regina Elena, Rome, Italy

Amancio Carnero, PhD

Instituto de Biomedicina de Sevilla (IBIS) (HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain

Gabriella Castoria, MD, PhD

Department of Precision Medicine, School of Medicine, University of Campania "L. Vanvitelli", Naples, Italy

Franco Cavalli, MD, FRCP (London)

Fondation for the Institute of Oncology Research (IOR), Bellinzona, Switzerland

Ammar Chaudhry, MD

Diagnostic Radiology and Imaging Informatics, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA

Simon K. Cheng, MD, PhD

Department of Radiation Oncology, Columbia University Irving Medical Center, New York, NY, USA

Lotfi Chouchane, PhD, DSc

Department of Genetic Medicine and Microbiology and Immunology, Weill Cornell Medicine, New York, NY, USA

Kevin Chua

Division of Radiation Oncology, National Cancer Centre, Singapore, Singapore

Eugenio Cocozza, MD

ASST Sette Laghi, Surgical Oncology and Minimally Invasive Unit, Varese, Italy

Giacomo Corrado, MD, PhD

Department of Woman and Child Health, Gynecologic Oncology Unit, Catholic University of Sacred Heart and “Agostino Gemelli” University Hospital Foundation - IRCCS, Rome, Italy

Cedric Coulouarn, PhD

Inserm UMR-1242, "Chemistry, Oncogenesis, stress, Signaling" (COSS), University of Rennes 1, Comprehensive Cancer Center Eugène Marquis, Rennes, France

Anita D'Souza, MD

Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA

Sanja Dacic, MD, PhD

Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Alessandro Di Stefani

Institute of Dematology, Catholic University of Rome, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

Manuel Cobo Dols, MD, PhD

Medical Oncology Department, University Regional Hospital of Málaga, IBIMA, Málaga, Spain

Simon Ekman, MD, PhD

Department of Oncology- Pathology, Karolinska Institutet, Stockholm, Sweden

Takayuki Enomoto, MD, PhD

Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

Chukwuka Eze, MD

Department of Radiation Oncology, Ludwig Maximilian University of Munich, Munich, Germany

Anthony C. Faber, PhD

Philips Institute for Oral Health Research, Virginia Commonwealth University School of Dentistry and Massey Cancer Center, Richmond, VA, USA

Françoise Farace, PhD

Head of the translational laboratory of rare circulating cells, CNRS UMS3655 - INSERM US23 AMMICA, head of circulating tumor cell team INSERM U981, Gustave Roussy, Villejuif, France

Benjamin W. Fischer-Valuck, MD

Department of Radiation Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA

Gianluca Franceschini, MD

Breast Unit, Department of Women’ and Children’s Health, Fondazione Policlinico Universitario Agostino Gemelli, Catholic University, Rome, Italy

Renato Franco, MD, PhD

Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples, Italy

Domenico Galetta, MD, PhD

Division of Thoracic Surgery, European Institute of Oncology, Milan, Italy

Daniele Generali, MD, DPhil

Medical Oncology, University of Trieste, Trieste, Italy; Women Cancer Centre, ASST of Cremona, Cremona, Italy

Vassilis Georgoulias, MD, PhD

Department of Medical Oncology, School of Medicine, University of Crete, Crete, Greece

Narayanan Gopalakrishna Iyer, MBBS (Hons), PhD (Cambridge), FRCSEd, FAMS

Department of Surgical Oncology, National Cancer Centre, Singapore, Singapore

Shilpa Gupta, MD

Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA

Balazs Halmos, MD

Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA

Gerhard Hamilton, PhD

Department of Surgery, Medical University of Vienna, Vienna, Austria

Peter S. Hammerman, MD, PhD

Novartis Institutes of Biomedical Research, Cambridge, MA, USA

Samir Hanash, MD, PhD

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Takuma Hayashi, MS, PharmD, PhD

Faculty of Medicine, Shinshu University Graduate School of Medicine, Nagano, Japan; National Hospital Organization Kyoto Medical Center, Kyoto, Kyoto, Japan

Lizza E. Hendriks, MD, PhD

Department of Pulmonary Diseases, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands

Université Côte d’Azur, CHU Nice, FHU OncoAge, Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Nice, France; Université Côte d’Azur, CNRS, INSERM, IRCAN, FHU OncoAge, Team 4, Nice, France; Université Côte d’Azur, CHU Nice, FHU OncoAge, Hospital-Integrated Biobank, Nice, France

Andrea Imperatori, MD

Center for Thoracic Surgery, Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy

Kentaro Inamura, MD, PhD

Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan

Eloisa Jantus Lewintre, PhD

Department of Biotechnology, Universitat Politècnica de València, Valencia, Spain

Jacek Jassem, MD, PhD

Medical University of Gdańsk, Gdańsk, Poland

Steve Jiang, PhD

Division of Medical Physics and Engineering, Department of Radiation Oncology, Medical Artificial Intelligence and Automation (MAIA) Laboratory, University of Texas Southwestern Medical Center, Dallas, TX, USA

Ravindran Kanesvaran, MD

Division of Medical Oncology, National Cancer Centre, Singapore, Singapore

Urna Kansakar, PhD

Department of Medicine, Case Western Reserve University, Cleveland, OH, USA

Lukas Käsmann, MD

Department of Radiation Oncology, Ludwig Maximilian University of Munich, Munich, Germany

Jaseok Peter Koo, PhD

Section of Medical Oncology, Department of Internal Medicine, Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT, USA

Robert Kratzke, MD

Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA

Prakash Kulkarni, PhD

Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA

Hiu Yee Kwan, PhD

Baptist University, Hong Kong, China

Giuseppe Lamberti, MD, PhD

Medical Oncology Department, University of Bologna, Bologna, Italy

John Le Quesne, MA, PhD, MB, BS

University of Glasgow, Glasgow, UK; MRC Toxicology Unit, University of Cambridge, Leicester, UK; Leicester Cancer Research Centre, University of Leicester, Leicester, UK; University Hospitals Leicester NHS Trust, Leicester, UK

Anna Marina Liberati, MD

Department of Onco-Hematology, University of Perugia, Perugia, Italy

Steven H. Lin

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Benjamin Lok, MD

Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Alexander V. Louie, MD, PhD, FRCPC

Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada

Maria D. Lozano. MD, PhD

Department of Pathology and Cytopathology, Clínica Universidad de Navarra, Pamplona, Spain

Bo Lu, MD, PhD

Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA

Abhishek Maiti, MBBS

Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX, USA

Natalia Malara, MD, PhD

Department of Experimental and Clinical Medicine, University of Magna Grecia, Catanzaro, Italy

Mario Mandalà, MD

Melanoma Unit, Division of Oncology, Papa Giovanni XXIII Hospital, Bergamo, Italy

Lucia Mangone, MD

AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy

Caterina Marchiò, MD, PhD

Department of Medical Sciences, University of Turin, Turin, Italy; Pathology Unit, FPO-IRCCS Candiolo Cancer Institute, Candiolo, Italy

Mozart Marins, BSc, PhD

Biotechnology Unit & Medicine School, University of Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil

Erminia Massarelli, MD, PhD, MS

Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA, USA

Francesco Massari, MD

Division of Oncology, S. Orsola-Malpighi Hospital, Bologna, Italy

Michael J. McKay, MBBS (Hons), FRANZCR, PhD, MD

School of Cancer Medicine, La Trobe University, Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia

Giulio Metro, MD

Department of Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy

Jean-Marie Michot, MD

Internal Medicine and Haematology, Departement des Innovations Therapeutiques et Essais Précoces (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif, France

Michael T. Milano, MD, PhD

Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA

Michele Mondini, PhD

INSERM U1030 Unit “Molecular Radiotherapy and Therapeutic Innovation at Gustave Roussy Cancer Campus, Villejuif, France

Matteo Morotti, MD, PhD

Ludwig Institute for Cancer Research Lausanne, Département d’oncologie UNIL-CHUV, Lausanne, Switzerland

Charles Mullighan, MBBS (Hons), MSc, MD

Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA

Ernest Nadal, MD, PhD

Section of Thoracic Tumors, Department of Medical Oncology, Catalan Institute of Oncology, L’Hospitalet, Barcelona, Spain

Eric Nadler, MD, MPP

Texas Oncology-Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, TX, USA

Nicola Normanno, MD

Cell Biology and Biotherapy Unit, Translational Research Department, Istituto Nazionale Tumori, IRCSS, Fondazione G. Pascale, Naples, Italy

Olorunseun Ogunwobi, MD, PhD

Department of Biological Sciences, Hunter College of The City University of New York, New York, NY, USA

Jose M. Pacheco, MD

Division of Medical Oncology, University of Colorado Anschutz Cancer Center, Aurora, CO, USA

Eugenio Paci, MD

Formerly Clinical Epidemiology Unit, ISPRO - Oncological Network, Prevention and Research Institute, Florence, Italy

Joshua D. Palmer, MD

Department of Radiation Oncology, The James Cancer Hospital & Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, USA

Andrea Papadia, MD, PhD

Department of Obstetrics and Gynecology, University Hospital of Bern and University of Bern, Bern, Switzerland; Department of Gynecology and Obstetrics, University of the Italian Switzerland (USI), Ente Ospedaliero Cantonale of Lugano, Lugano, Switzerland

Former Section Editor

Lin Tian, PhD

Post-doctoral Research Fellow, Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center